Advertisement
Canada markets close in 57 minutes

  • S&P/TSX

    21,850.20
    -161.52 (-0.73%)
     

  • S&P 500

    5,061.61
    -8.94 (-0.18%)
     

  • DOW

    38,419.00
    -84.69 (-0.22%)
     

  • CAD/USD

    0.7297
    -0.0023 (-0.32%)
     

  • CRUDE OIL

    82.89
    -0.47 (-0.56%)
     

  • Bitcoin CAD

    87,842.00
    -3,721.35 (-4.06%)
     

  • CMC Crypto 200

    1,392.18
    -31.92 (-2.24%)
     

  • GOLD FUTURES

    2,333.50
    -8.60 (-0.37%)
     

  • RUSSELL 2000

    1,991.70
    -10.95 (-0.55%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ

    15,671.23
    -25.41 (-0.16%)
     

  • VOLATILITY

    15.95
    +0.26 (+1.66%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6820
    -0.0016 (-0.23%)
     
MARKETS LIVE BLOG:

STOCKS SHED GAINS, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Roche, Spark extend $4.3 billion takeover again, this time to September 3

Reuters
FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

ZURICH (Reuters) - Roche <ROG.S> and Spark Therapeutics <ONCE.O> announced another extension of the Swiss drugmaker's $4.3 billion (£3.5 billion) takeover offer for the U.S. gene therapy specialist as regulatory reviews in the United States and Britain continue.

The offer for Spark shares now runs to Sept. 3, Roche said, adding terms and conditions are unchanged. "The parties remain committed to the transaction and are working cooperatively and expeditiously with the Federal Trade Commission and UK Competition and Markets Authority," Roche said.

(Reporting by John Miller; Editing by Thomas Seythal)